Abstract
Viruses persist in an immune population, as in the case of influenza, or in an individual, as postulated for human immunodeficiency virus, when they are able to escape existent neutralizing antibody responses by changing their antigens. It is now shown that viruses can in principle escape the immunosurveillance of virus-specific cytotoxic T cells by mutations that alter the relevant T-cell epitope.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks
Nature Communications Open Access 02 December 2021
-
Exhausted CD8+ T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection
Nature Communications Open Access 08 September 2020
-
Tcf1+ cells are required to maintain the inflationary T cell pool upon MCMV infection
Nature Communications Open Access 08 May 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mims, C. A. Pathogenesis of Infectious Disease (Academic, London, 1982).
Stevens, J. G. & Cook, M. L. Science 173, 843–845 (1971).
Notkins, A. L. & Oldstone, M. B. A. Concepts in Viral Pathogenesis (Springer, New York, 1984).
Fenyö, E. M. et al. J. Virol. 62, 4414–4419 (1988).
Sakai, K., Dewhurst, St., Ma, X. & Volsky, D. J. J. Virol. 62, 4078–4085 (1988).
Gendelman, H. E. et al. J. exp. Med. 167, 1428–1441 (1988).
Fisher, A. G. et al. Nature 334, 444–447 (1988).
Riviere, Y. & Oldstone, M. B. A. J. Virol. 59, 363–368 (1986).
Riviere, Y. Curr. Topics Microbiol. Immun. 133, 59–65 (1987).
Joseph, B. S. & Oldstone, M. B. A. J. exp. Med. 142, 864–876 (1975).
Kvist, S., Östberg, L., Persson, H., Philipson, L. & Peterson, P. A. Proc. natn. Acad. Sci. U.S.A. 75, 5674–5678 (1978).
Bernards, R. et al. Nature 305, 776–779 (1983).
Gresser, I. & Lang, D. J. Prog. med. Virol. 8, 62–130 (1966).
Glasgow, L. A. Fedn Proc. 30, 1846–1851 (1971).
Dent, P. B. Prog. med. Virol. 14, 1–35 (1972).
Arala-Chaves, M. P. et al. Am. J. vet. Res. 49, 1955–1961 (1988).
Diamond, D. C. et al. J. Immun. 141, 3715–3717 (1988).
Laver, W. G. & Webster, R. G. Virology 51, 383–390 (1973).
Narayan, O., Griffin, D. E. & Chase, J. Science 197, 376–378 (1977).
Wiktor, T. J. & Koprowski, H. Proc. natn. Acad. Sci. U.S.A. 75, 3938–3942 (1978).
Laver, W. G. et al. Virology 98, 226–237 (1979).
Yewdell, J. W., Webster, R. G. & Gerhard, W. U. Nature 279, 246–248 (1979).
De St. Groth, S. F. The Immune System 1, 155–168 (1981).
Palese, P. & Young, J. F. Science 215, 1468–1474 (1982).
McClure, H. M. et al. Vet. Immunol. Immunopathol. 21, 13–24 (1989).
Pozsgay, J. M., Klyczek, K. K. & Blank, K. J. Virology 173, 330–334 (1989).
Levy, G. A. Nature 333, 519–522 (1988).
Rosenberg, Z. F. & Fauci, A. S. in Advances in Immunology (ed. Dixon, F. J.) 377–431 (Academic, New York, 1989).
Hotchin, J. Cold Spring Harb. Symp. quant. Biol. 27, 479–499 (1962).
Lehmann-Grube, F. Virol. Monogr. 10, 1–173 (1971).
Zinkernagel, R. M. & Doherty, P. C. Adv. Immun. 27, 52–142 (1979).
Oldstone, M. B. A. Curr. Topics Microbiol. Immun. 133, 1–4 (1987).
Zinkernagel, R. M. & Welsh, R. M. J. Immun. 117, 1495–1502 (1976).
Byrne, J. A. & Oldstone, M. B. A. J. Virol. 51, 682–686 (1984).
Moskophidis, D., Cobbold, S. P., Waldmann, H. & Lehmann-Grube, F. J. Virol. 61, 1867–1874 (1987).
Cole, G. A., Nathanson, N. & Prendergast, R. A. Nature 238, 335–337 (1972).
Doherty, P. C., Allan, J. E., Lynch, F. & Ceredig, R. Immunol. Today 11, 55–59 (1990).
Baenziger, J., Hengartner, H., Zinkernagel, R. M. & Cole, G. A. Eur. J. Immun. 16, 387–393 (1986).
Pircher, H. P. et al. Eur. J. Immun. 17, 159–166 (1987).
Pircher, H. P. et al. Eur. J. Immun. 17, 1843–1846 (1987).
Mclntyre, K. W., Bukowski, J. F. & Welsh, R. M. Antiviral Res. 5, 299–305 (1985).
Aebischer, T., Oehen, S. & Hengartner, H. Eur. J. Immun. 20, 523–531 (1990).
Oldstone, M. B., Whitton, J. L., Lewicki, H. & Tishon, A. J. exp. Med. 168, 559–570 (1988).
Romanowski, V., Matsuura, Y. & Bishop, D. H. L. Virus Res. 3, 101–114 (1985).
Southern, P. J. et al. Virology 157, 145–155 (1987).
Zinkernagel, R. M. & Doherty, P. C. Nature 248, 701–702 (1974).
Townsend, A. R. M. et al. Cell 44, 959–968 (1986).
Cattaneo, R., Schmid, A., Billeter, M. A., Shepard, R. D. & Udem, S. A. J. Virol. 62, 1388–1397 (1988).
Murray, R. J., Gregory, C. D., Moss, D. J. & Rickinson, A. B. Prog. Immun. 7, 939–945 (1989).
White, H. D., Robbins, M. D. & Green, W. R. J. Virol. 64, 2608–2619 (1990).
Boon, T. & Van Pel, A. Immunogenetics 29, 75–79 (1989).
Romero, P. et al. Nature 341, 323–325 (1989).
Pircher, H. P. et al. EMBO J. 8, 719–727 (1989).
Pircher, H. P., Bürki, K., Lang, R., Hengartner, H. & Zinkernagel, R. Nature 342, 559–561 (1989).
Tomonari, K. Immunogenetics 28, 455–458 (1988).
Haskins, K. et al. J. exp. Med. 160, 452–471 (1984).
Lehmann-Grube, F. & Ambrassat, J. J. gen. Virol. 37, 85–92 (1977).
Popescu, M. & Lehmann-Grube, F. J. gen. Virol. 30, 113–122 (1976).
Hany, M. et al. Eur. J. Immun. 19, 417–424 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pircher, H., Moskophidis, D., Rohrer, U. et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629–633 (1990). https://doi.org/10.1038/346629a0
Issue Date:
DOI: https://doi.org/10.1038/346629a0
This article is cited by
-
CD8+ T cell differentiation and dysfunction in cancer
Nature Reviews Immunology (2022)
-
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks
Nature Communications (2021)
-
Exhausted CD8+ T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection
Nature Communications (2020)
-
Tcf1+ cells are required to maintain the inflationary T cell pool upon MCMV infection
Nature Communications (2020)
-
TIGIT limits immune pathology during viral infections
Nature Communications (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.